What is JBIO's current ratio?

JBIO (JBIO) reported current ratio of 14.3× in Q1 2026.

How has JBIO's current ratio changed year-over-year?

JBIO's current ratio decreased by 55.4% year-over-year, from 32× to 14.3×.

What is the long-term trend for JBIO's current ratio?

Over 5 years (2020 to 2025), JBIO's current ratio has grown at a 51.6% compound annual growth rate (CAGR), from 2.6× to 21.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

JBIO JBIO Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3×+0.4×

Travere Therapeutics, Inc.TVTX

3.1×+1.1×

Vera TherapeuticsVERA

13.6×-14.0×

AnaptysBio, Inc.ANAB

7.6×-0.7×

Cullinan Therapeutics, Inc.CGEM

10.3×-1.3×

Viridian Therapeutics, Inc.VRDN

15.1×-4.3×

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B—

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Where this comes from

Calculated from JBIO’s reported figures.

total current assets/total current liabilities=14.3×

Based on the most recent quarter.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's current ratio?: JBIO (JBIO) reported current ratio of 14.3× in Q1 2026.
How has JBIO's current ratio changed year-over-year?: JBIO's current ratio decreased by 55.4% year-over-year, from 32× to 14.3×.
What is the long-term trend for JBIO's current ratio?: Over 5 years (2020 to 2025), JBIO's current ratio has grown at a 51.6% compound annual growth rate (CAGR), from 2.6× to 21.1×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.